"pet construct has conditional approval and looks very promising for further research but we need partner to pay"
We have a partner that we did a full licensing deal with, PETX. They have rights for the current conditionally approved construct plus are developing and paying for several of our other vet constructs. The problem is the deal was crap. O'Connor gave away all of the rights for only $1.5 million upfront and the total milestone potential payments from the PETX deal are only around $30 million for all the vet constructs. That's why the stock didn't move an inch when the vet construct got conditional approval, because there is very little monetary value to ADXS.
Market Data 
Markets 
AI
